SG161258A1 - Methods and compositions for enhancing vascular access - Google Patents

Methods and compositions for enhancing vascular access

Info

Publication number
SG161258A1
SG161258A1 SG201002482-6A SG2010024826A SG161258A1 SG 161258 A1 SG161258 A1 SG 161258A1 SG 2010024826 A SG2010024826 A SG 2010024826A SG 161258 A1 SG161258 A1 SG 161258A1
Authority
SG
Singapore
Prior art keywords
implantable material
cells
methods
present
functional
Prior art date
Application number
SG201002482-6A
Other languages
English (en)
Inventor
Helen Marie Nugent
Elazer Edelman
Anupam Dalal
Steve Bollinger
Scott Epperly
Original Assignee
Pervasis Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/043967 external-priority patent/WO2006062909A2/en
Application filed by Pervasis Therapeutics Inc filed Critical Pervasis Therapeutics Inc
Publication of SG161258A1 publication Critical patent/SG161258A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)
SG201002482-6A 2005-06-21 2006-06-05 Methods and compositions for enhancing vascular access SG161258A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69270805P 2005-06-21 2005-06-21
PCT/US2005/043967 WO2006062909A2 (en) 2004-12-08 2005-12-06 Methods and compositions for enhancing vascular access

Publications (1)

Publication Number Publication Date
SG161258A1 true SG161258A1 (en) 2010-05-27

Family

ID=39892157

Family Applications (2)

Application Number Title Priority Date Filing Date
SG201002482-6A SG161258A1 (en) 2005-06-21 2006-06-05 Methods and compositions for enhancing vascular access
SG2013075387A SG195537A1 (en) 2005-06-21 2006-06-05 Methods and compositions for enhancing vascular access

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2013075387A SG195537A1 (en) 2005-06-21 2006-06-05 Methods and compositions for enhancing vascular access

Country Status (10)

Country Link
US (2) US20090035346A1 (https=)
EP (2) EP2361591A3 (https=)
JP (2) JP5632580B2 (https=)
CN (3) CN101878757A (https=)
AU (1) AU2006262682B2 (https=)
CA (2) CA2818182C (https=)
ES (1) ES2541684T3 (https=)
IL (2) IL188263A (https=)
SG (2) SG161258A1 (https=)
WO (1) WO2007001744A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2926510B2 (ja) 1990-08-09 1999-07-28 京都電子工業株式会社 アンモニア濃度測定装置
CA2605080A1 (en) 2005-04-21 2006-11-02 Massachusetts Institute Of Technology Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
EP2361591A3 (en) 2005-06-21 2011-12-21 Pervasis Therapeutics, Inc. Methods and compositions for enhancing vascular access
JP5372764B2 (ja) * 2006-11-07 2013-12-18 シャイア リジェネラティブ メディシン， インコーポレイテッド 血管形成関連疾患の治療および管理のための材料および方法
WO2008057590A2 (en) * 2006-11-07 2008-05-15 Pervasis Therapeutics, Inc. Methods and compositions for modulating tissue modeling
EP2240116B1 (en) 2008-01-28 2015-07-01 Biomet 3I, LLC Implant surface with increased hydrophilicity
KR101970342B1 (ko) * 2011-04-28 2019-04-18 아브락시스 바이오사이언스, 엘엘씨 나노입자 조성물의 혈관내 전달 및 그의 용도
CN102763642B (zh) * 2012-08-14 2014-04-02 郑州赛英科干细胞技术有限公司 一种冷冻保护液以及冷冻保存人胎盘羊膜和绒毛膜的方法
AU2015265954A1 (en) * 2014-05-27 2017-01-12 Novahep Ab Bioengineered allogeneic valve
CA3222892A1 (en) * 2015-03-10 2016-09-15 Stent Tek Limited Surgical system, device and methods of use thereof for the percutaneous creation of an arteriovenous fistula (avf)
US11389622B1 (en) * 2017-11-13 2022-07-19 Simon B. Rayhanabad Patch for providing dialysis
US12017032B1 (en) 2017-11-13 2024-06-25 Sbr Innovations, Llc Arteriovenous graft and method of using thereof
WO2019152799A1 (en) 2018-02-02 2019-08-08 University Of Louisville Research Foundation, Inc. Sutureless graft anastomotic quick connect system
JP7669266B2 (ja) * 2018-08-31 2025-04-28 ウィスコンシン アラムニ リサーチ ファンデーション 動脈内皮細胞を播種した血管移植片の生成
US12310836B2 (en) 2020-03-03 2025-05-27 Akeo Hagiwara Vein cover
CN115376392B (zh) * 2022-08-18 2024-04-26 昆明理工大学 主动脉老化对血管生物力学影响的模拟装置及方法
EP4439070B1 (de) * 2023-03-27 2025-12-03 Siemens Healthcare Diagnostics Products GmbH Automatisches analysesystem
CN120227529B (zh) * 2025-05-29 2025-08-12 鼎科医疗技术（苏州）有限公司 一种血管外支架

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418691A (en) * 1981-10-26 1983-12-06 Massachusetts Institute Of Technology Method of promoting the regeneration of tissue at a wound
US4787900A (en) * 1982-04-19 1988-11-29 Massachusetts Institute Of Technology Process for forming multilayer bioreplaceable blood vessel prosthesis
US4820626A (en) * 1985-06-06 1989-04-11 Thomas Jefferson University Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself
IL78950A (en) 1985-06-06 1991-12-15 Univ Jefferson Coating for prosthetic devices
US4732155A (en) * 1985-08-27 1988-03-22 The Children's Medical Center Corporation Implantable chemoattractant system
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US6309635B1 (en) * 1986-11-20 2001-10-30 Children's Medical Center Corp. Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
CA1340581C (en) * 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5567612A (en) * 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
US5804178A (en) * 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
US5736372A (en) * 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
US5145769A (en) * 1987-08-21 1992-09-08 Cryolife Inc. Method for cryopreserving blood vessels
US5202120A (en) * 1987-09-11 1993-04-13 Case Western Reserve University Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
US4945086A (en) 1988-05-03 1990-07-31 The Board Of Trustees Of The Leland Stanford Junior University Smooth muscle cell growth inhibitor
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5575815A (en) * 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
CH676195A5 (https=) * 1988-10-07 1990-12-28 Sulzer Ag
JPH03133901A (ja) * 1989-10-19 1991-06-07 Osaka Gas Co Ltd 生体細胞の凍結保存方法
US5527532A (en) * 1989-11-13 1996-06-18 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
WO1991007154A1 (en) * 1989-11-13 1991-05-30 President And Fellows Of Harvard College EXTRALUMINAL REGULATION OF THE GROWTH AND REPAIR OF TUBULAR STRUCTURES ιIN VIVO
US5540928A (en) * 1991-02-27 1996-07-30 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
EP1041142A3 (en) 1991-07-15 2007-10-24 Oklahoma Medical Research Foundation Universal donor cells
US5336615A (en) 1992-01-06 1994-08-09 Yale University Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity
JPH0646840A (ja) * 1992-08-04 1994-02-22 Nippon Zenyaku Kogyo Kk 細胞凍結保存液
US5399665A (en) * 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
US6491938B2 (en) * 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
GB9306449D0 (en) * 1993-03-29 1993-05-19 Nat Heart Research Fund Tissue equivalents
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5645829A (en) * 1993-06-18 1997-07-08 Beth Israel Hospital Association Mesothelial cell gene therapy
US6176874B1 (en) * 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
US6608182B1 (en) * 1994-03-08 2003-08-19 Human Genome Sciences, Inc. Human vascular endothelial growth factor 2
EP0757562A1 (en) 1994-04-29 1997-02-12 W.L. Gore & Associates, Inc. Improved blood contact surfaces using endothelium on a subendothelial extracellular matrix
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
US6911216B1 (en) * 1994-10-12 2005-06-28 Genzyme Corporation Targeted delivery via biodegradable polymers
CA2202511A1 (en) * 1994-10-12 1996-04-25 Laurence A. Roth Targeted delivery via biodegradable polymers
US5914268A (en) * 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
US5716404A (en) * 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US5855610A (en) * 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US5766584A (en) * 1995-06-02 1998-06-16 Massachusetts Institute Of Technology Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells
US6615071B1 (en) * 1995-09-20 2003-09-02 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
US5897987A (en) * 1996-03-25 1999-04-27 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media
US6886568B2 (en) * 1998-04-08 2005-05-03 The Johns Hopkins University Method for fabricating cell-containing implants
EP1144594A1 (en) * 1998-11-24 2001-10-17 Regents Of The University Of Minnesota Transgenic circulating endothelial cells
US6328762B1 (en) * 1999-04-27 2001-12-11 Sulzer Biologics, Inc. Prosthetic grafts
US6387116B1 (en) * 1999-06-30 2002-05-14 Pharmasonics, Inc. Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
AU2001243248A1 (en) * 2000-02-23 2001-09-03 Smith Kline Beecham Corporation Method for the prevention or reduction of vascular access dysfunction
EP1263803B1 (en) * 2000-03-13 2007-09-19 BioCure, Inc. Embolic compositions
AU2001245734A1 (en) * 2000-03-15 2001-09-24 Orbus Medical Technologies Inc. Coating that promotes endothelial cell adherence
EP1269840A4 (en) 2000-03-24 2009-05-06 Menicon Co Ltd METHOD FOR PRESERVING A TISSUE TREATMENT AND IN THE FROZEN CONSERVATED TISSUE REPLACEMENT
US6506398B1 (en) * 2000-04-28 2003-01-14 Hosheng Tu Device for treating diabetes and methods thereof
WO2001095717A2 (en) * 2000-06-09 2001-12-20 Organ Recovery Systems Cryopreservation method using cryoprotective composition of propanediol and a vehicle solution
US20020137706A1 (en) 2000-07-21 2002-09-26 Evans Gregory R.D. Regulated growth factor delivery for engineered peripheral nerve
AU2001296558A1 (en) * 2000-10-03 2002-04-15 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
JP2002200161A (ja) * 2000-10-24 2002-07-16 Menicon Co Ltd 培養皮膚代替物の製造方法およびそれにより得られる培養皮膚代替物
US6565601B2 (en) * 2000-11-15 2003-05-20 Micro Therapeutics, Inc. Methods for vascular reconstruction of diseased arteries
AU2002246747A1 (en) * 2000-12-27 2002-08-06 Ortec International, Inc. Processes for making cryopreserved composite living constructs and products resulting therefrom
AU2002249958B2 (en) * 2001-01-16 2007-11-08 Vascular Therapies, Inc. Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US6723131B2 (en) 2001-02-28 2004-04-20 The Cleveland Clinic Foundation Composite bone marrow graft material with method and kit
WO2003026489A2 (en) 2001-09-28 2003-04-03 University Of Florida Biopolymer and biopolymer-cell compositions for nerve tissue repair
US7297540B2 (en) * 2002-01-15 2007-11-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs
US20040047843A1 (en) * 2002-02-12 2004-03-11 Uab Research Foundation Method for spinal cord reconnection
WO2003083044A2 (en) * 2002-03-25 2003-10-09 Condros, Inc. Tissue analogs for in vitro testing and method of use therefor
US20050008629A1 (en) * 2002-05-08 2005-01-13 Interpore Orthopaedics, A Delaware Corporation Encapsulated AGF cells
CA2490811A1 (en) * 2002-06-28 2004-01-08 Novartis Ag Use of organic compounds
FR2845691B1 (fr) * 2002-10-10 2004-12-10 Centre Nat Rech Scient Nouvelles cellules endotheliales, anticorps diriges contre ces cellules et leur utilisation, notamment pour le criblage de substances inhibant l'angiogenese
US20040156878A1 (en) * 2003-02-11 2004-08-12 Alireza Rezania Implantable medical device seeded with mammalian cells and methods of treatment
WO2004111207A1 (en) * 2003-06-09 2004-12-23 Centelion Multicellular in vitro model of angiogenesis and methods for using the same
WO2005003317A2 (en) * 2003-07-01 2005-01-13 Regents Of The University Of Minnesota Engineered blood vessels
GB0322789D0 (en) * 2003-09-30 2003-10-29 Lifeforce Group Plc Blood pack for leukocyte banking
WO2005052138A1 (en) * 2003-11-19 2005-06-09 Wisconsin Alumni Research Foundation Cryopreservation of pluripotent stem cells
WO2005072417A2 (en) * 2004-01-27 2005-08-11 The Ohio State University Research Foundation Vascular endothelial growth factors and methods of their use
US7670596B2 (en) * 2004-04-23 2010-03-02 Bioe, Inc. Multi-lineage progenitor cells
FR2869533B1 (fr) 2004-05-03 2006-07-28 Sedat Sa Seringue pour interventions medicales et necessaire de reconstitution de substances extemporanees comportant une telle seringue
US7842304B2 (en) 2004-10-29 2010-11-30 Nexeon Medsystems, Inc. Methods and apparatus for treating an injured nerve pathway
WO2006062871A2 (en) 2004-12-08 2006-06-15 Pervasis Therapeutics, Inc. Materials and methods for minimally-invasive administration of a cell-containing flowable composition
ATE450276T1 (de) 2004-12-08 2009-12-15 Pervasis Therapeutics Inc Materialien und verfahren zur minimal invasiven abgabe einer zellhaltigen fliessfähigen zusammensetzung
WO2006062909A2 (en) * 2004-12-08 2006-06-15 Pervasis Therapeutics, Inc. Methods and compositions for enhancing vascular access
CA2605080A1 (en) 2005-04-21 2006-11-02 Massachusetts Institute Of Technology Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
GB0509845D0 (en) 2005-05-13 2005-06-22 Btg Int Ltd Preparation of therapeutic foam
EP2361591A3 (en) 2005-06-21 2011-12-21 Pervasis Therapeutics, Inc. Methods and compositions for enhancing vascular access
JP5015160B2 (ja) 2005-10-12 2012-08-29 セルラー・バイオエンジニアリング・インコーポレイテッド 再吸収可能な角膜ボタン（ｒｅｓｏｒｂａｂｌｅｃｏｒｎｅａｂｕｔｔｏｎ）
US7882863B2 (en) * 2005-10-19 2011-02-08 Cd Solutions, Llc Apparatus and method for mixing and transferring medications
AU2006348410B2 (en) * 2005-11-07 2011-12-15 Industrie Borla S.P.A. Vented safe handling vial adapter

Also Published As

Publication number Publication date
ES2541684T3 (es) 2015-07-23
CN102743792A (zh) 2012-10-24
WO2007001744A2 (en) 2007-01-04
EP2361591A2 (en) 2011-08-31
EP1901680A2 (en) 2008-03-26
EP2361591A3 (en) 2011-12-21
JP5632580B2 (ja) 2014-11-26
EP1901680B1 (en) 2015-04-15
IL188263A (en) 2014-05-28
IL220806A (en) 2014-05-28
CN102743792B (zh) 2014-09-24
AU2006262682B2 (en) 2012-07-05
AU2006262682A1 (en) 2007-01-04
JP2012166084A (ja) 2012-09-06
WO2007001744B1 (en) 2007-12-21
CN101257861A (zh) 2008-09-03
SG195537A1 (en) 2013-12-30
IL188263A0 (en) 2009-02-11
IL220806A0 (en) 2012-08-30
WO2007001744A3 (en) 2007-10-04
JP2008546406A (ja) 2008-12-25
US20090035346A1 (en) 2009-02-05
US20130210142A1 (en) 2013-08-15
CA2818182C (en) 2015-04-14
CA2818182A1 (en) 2007-01-04
CN101257861B (zh) 2012-12-05
CN101878757A (zh) 2010-11-10
CA2612751A1 (en) 2007-01-04
US9023377B2 (en) 2015-05-05

Similar Documents

Publication Publication Date Title
IL183786A0 (en) Methods and compositions for enhancing vascular access
SG161258A1 (en) Methods and compositions for enhancing vascular access
Yao et al. Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity
EP1795213A3 (en) Implantable microbial cellulose materials for various medical applications
MX2009001323A (es) Aposito solido para tratar tejido herido.
EP2420568A3 (en) Methods and compositions for treatment of bone defects with placental cell populations
KR102269612B1 (ko) 미용적 유방 충전을 위해 또는 안면 충전 및/또는 회생을 위해 체외 확장 지방조직-유래 줄기세포를 이용하는 지방 충전물
WO2004101758A3 (en) Composition for maintaining organ and cell viability
AU3155700A (en) New biomaterials
WO2009100280A3 (en) 3-dimensional silk hydroxyapatite compositions
ATE508758T1 (de) Nicht-abbaubare wenig quellende wasserlösliche röntgendichte hydrogels
WO2002076285A3 (en) Composition and methods fro the production of biological tissues and tissue constructs
WO2008134610A8 (en) Growth factor modified extracellular matrix material and methods for preparation and use thereof
AU2003257319A1 (en) Biocompatible porous ti-ni material
WO2005012492A8 (en) Human skin equivalents expressing exogenous polypeptides
WO2008101566A3 (de) Verfahren zur behandlung biologischer gewebe tierischen oder menschlichen ursprungs wie schweine-, rinderperikard- oder menschlicher leichen-herzklappen sowie entsprechend behandeltes biologisches gewebe
ATE411057T1 (de) Injizierbare implantate auf keramikbasis zur füllung von weichgewebe
WO2006093857A3 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
GB2434105A (en) Fibronectin-modified ECM tissue graft constructs and methods for preparation and use thereof
WO2003099230A3 (en) Electroprocessed collagen and tissue engineering
RU2539918C1 (ru) Способ получения тканеспецифического матрикса для тканевой инженерии паренхиматозного органа
WO2006062909A3 (en) Methods and compositions for enhancing vascular access
EP2198895A8 (en) Porous structures of microbial-derived cellulose for in vivo implantation
WO2010047587A3 (en) Implant for prostheses
Sharma et al. Albumin removal from human fibrinogen preparations for manufacturing human fibrin-based biomaterials